Xtant Medical Holdings, Inc.
XTNT
$0.36
-$0.02-6.26%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.27% | -0.32% | 14.21% | 16.88% | 15.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.27% | -0.32% | 14.21% | 16.88% | 15.16% |
| Cost of Revenue | -12.62% | -10.24% | 1.23% | 13.49% | 19.53% |
| Gross Profit | -15.37% | 6.81% | 23.54% | 19.06% | 12.44% |
| SG&A Expenses | -8.42% | -7.58% | -3.87% | -8.57% | -6.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.95% | -8.65% | -2.09% | -0.88% | 2.56% |
| Operating Income | -19,725.00% | 143.73% | 160.32% | 145.33% | 100.21% |
| Income Before Tax | -116.47% | 132.83% | 143.05% | 113.41% | 13.81% |
| Income Tax Expenses | 506.39% | 2,112.77% | 984.49% | -31.63% | 119.33% |
| Earnings from Continuing Operations | -143.11% | 115.23% | 130.23% | 109.96% | -37.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -143.11% | 115.23% | 130.23% | 109.96% | -37.44% |
| EBIT | -19,725.00% | 143.73% | 160.32% | 145.33% | 100.21% |
| EBITDA | -132.79% | 345.64% | 259.30% | 210.01% | 146.29% |
| EPS Basic | -153.67% | 115.28% | 129.60% | 111.44% | -27.76% |
| Normalized Basic EPS | -206.59% | 105.40% | 122.39% | 114.17% | 77.33% |
| EPS Diluted | -108.84% | 108.15% | 124.07% | 107.16% | -47.21% |
| Normalized Diluted EPS | -189.12% | 103.35% | 120.91% | 112.24% | 75.63% |
| Average Basic Shares Outstanding | -2.08% | -0.67% | 0.74% | 9.66% | 10.24% |
| Average Diluted Shares Outstanding | -0.70% | 3.97% | 7.03% | 14.26% | 11.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |